New SOD-2 mimetics have been developed to reduce OS after radiotherapy in cancer patients, Avasopasem Manganese (GC4419 AVA), selectively reduces superoxide dismutase and peroxide in cancer patients [110]. Here, SOD2 is linked to cancer.